Jakub P. Jozwiak
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/31604_jjozwiak_0.jpg?itok=ETXclObZ)
Filters
TransMedics Group $150 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Dun & Bradstreet $460 million senior notes offering
The high-yield notes are due 2029
Fifth Third Bancorp $500 million inaugural sustainable notes offering
The company offered fixed-rate/floating-rate senior notes due 2027
SOPHiA GENETICS $234 million IPO and $20 million private placement
We advised SOPHiA GENETICS on its IPO, Nasdaq listing and concurrent private placement
Nubank $750 million Series G-1 financing
We advised Nubank on its Series G-1 financing
Disruptive Acquisition Corporation I $250 million IPO
We advised Disruptive Acquisition Corporation I, a SPAC, on its IPO and Nasdaq listing
Itiquira Acquisition $230 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
Rotor Acquisition $276 million IPO
We advised the underwriter on the SPAC IPO and NYSE listing
Peabody Energy transaction support agreement and out-of-court notes exchange
Davis Polk is advising an ad hoc group of noteholders holding approximately 65% of Peabody Energy’s outstanding 6.000% senior secured notes due 2022, in connection with a notes amendment…
Marquee Raine Acquisition $373.75 million IPO
Davis Polk advised the sole underwriter in connection with the initial public offering of 37,375,000 units of Marquee Raine Acquisition Corp., including 4,875,000 units purchased pursuant…